John Russell  
Chairman and CEO
John is responsible for running the board and setting its agenda while ensuring that members of the board receive accurate, timely and clear information about the company’s performance to enable the board to make sound decisions, monitor effectively and provide advice to promote the success of the company. He is responsible for communication with shareholders and he is a member of the remuneration and audit committees. John is a former investment banker with broad business and corporate governance experience. He joined the Board as a Non-executive Director in April 2005 and was appointed Non Executive Chairman in March 2007. He has more than 30 years of investment banking experience in Sydney, London and New York at a senior level with Bain & Co and then Deutsche Bank AG. He left Deutsche Bank in 1999. Since then he has been a consultant and corporate finance adviser to smaller British and Australian companies in the technology sector. John is also Chairman of Henderson Far East Income Limited.

Karl Keegan, PhD, MSc
Chief Financial Officer
Dr Keegan, aged 42 years, joins Minster from the investment bank CanaccordAdams, where he has worked for six years most recently as Managing Director and UK Head of Equity Research and Global Head of Life Sciences Research. During more than 11 years in the City, he worked at investment banks including Banc of America, UBS and DresdnerKleinwort Benson, achieving the top ranking in investor surveys of biotechnology analysts.
Prior to joining the City, Dr Keegan worked in the pharmaceutical industry in research and in commercial strategy at companies including SmithKline Beecham Pharmaceuticals, which later became GlaxoSmithKline.
Dr Keegan graduated in Pharmacology at University College Dublin, Ireland, and gained a PhD in Pharmacology at the University of Cambridge, UK. He also holds an MSc in Finance from the London Business School.